The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).

Olulade AyodeleHoward J CabralDavid McManusSusan S Jick

Published in: Clinical epidemiology (2021)

Current use of 5ARI, particularly long-term use, is associated with an increased risk of incident idiopathic VTE compared to patients treated with AB use only.

Keyphrases

venous thromboembolism
benign prostatic hyperplasia
lower urinary tract symptoms
direct oral anticoagulants
cardiovascular disease
middle aged
type diabetes
newly diagnosed